Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

休市中 10-04 16:00:00 EDT

12.00

+0.60

+5.26%

盘后12.00

+0.000.00%

19:59 EDT

最高12.28	最低11.79	成交量3.71万
今开12.00	昨收11.40	日振幅4.32%
总市值1,281万	流通市值682.29万	总股本106.72万
成交额44.45万	换手率6.52%	流通股本56.86万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":12,"timestamp":1728072000000,"preClose":11.4,"halted":0,"volume":37065,"hourTrading":{"tag":"盘后","latestPrice":12,"preClose":12,"latestTime":"19:59 EDT","volume":79,"amount":981.1,"timestamp":1728086369542},"delay":0,"floatShares":568577,"shares":1067231,"eps":-5.894961,"marketStatus":"休市中","marketStatusCode":7,"change":0.6,"latestTime":"10-04 16:00:00 EDT","open":12,"high":12.2825,"low":11.79,"amount":444534.073725,"amplitude":0.043202,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.894961,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1728288000000},"adr":0,"listingDate":1674190800000,"adjPreClose":11.4,"preHourTrading":{"tag":"盘前","latestPrice":11.97,"preClose":11.4,"latestTime":"09:12 EDT","volume":171,"amount":1982.660013,"timestamp":1728047566991},"postHourTrading":{"tag":"盘后","latestPrice":12,"preClose":12,"latestTime":"19:59 EDT","volume":79,"amount":981.1,"timestamp":1728086369542},"volumeRatio":0.7528272931692273},"requestUrl":"/m/hq/s/CVKD","defaultTab":"news","newsList":[{"id":"2472952302","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952302?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:37","pubTimestamp":1728049023,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时37分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速上涨5.26%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042137049719e603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042137049719e603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2472615470","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅下挫7.95%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472615470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472615470?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:33","pubTimestamp":1727962431,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时33分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下挫7.95%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100321335198e3a670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100321335198e3a670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CVKD","LENZ"],"gpt_icon":0},{"id":"2472521566","title":"Cadrenal Therapeutics, Inc.盘中异动 急速下挫8.07%报11.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472521566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472521566?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:52","pubTimestamp":1727877178,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时52分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速跳水8.07%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022152589719df51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022152589719df51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CVKD","BK4007"],"gpt_icon":0},{"id":"2472358194","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下挫5.45%报13.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472358194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472358194?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:01","pubTimestamp":1727722895,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时01分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅下跌5.45%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100103013598e39e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100103013598e39e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CVKD","LENZ"],"gpt_icon":0},{"id":"2470731707","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速拉升6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470731707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470731707?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:34","pubTimestamp":1727357679,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时34分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速拉升6.56%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262134399f18753f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262134399f18753f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2469413090","title":"Cadrenal Therapeutics, Inc.盘中异动 急速上涨5.60%报10.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469413090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469413090?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:19","pubTimestamp":1727191199,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时19分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.60%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423195998e38af3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423195998e38af3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CVKD","LENZ"],"gpt_icon":0},{"id":"2469117460","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469117460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469117460?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:48","pubTimestamp":1727099302,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时48分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速下跌5.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321482298e38706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321482298e38706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2468689102","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468689102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468689102?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:39","pubTimestamp":1726771170,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时39分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速下挫5.79%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092002393098e3827a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092002393098e3827a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CVKD"],"gpt_icon":0},{"id":"2460000314","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460000314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460000314?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:07","pubTimestamp":1724162831,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时07分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升6.44%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220711971994fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220711971994fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CVKD"],"gpt_icon":0},{"id":"2459212600","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459212600","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459212600?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:36","pubTimestamp":1723815419,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时36分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下挫5.32%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816213659a1d4adcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816213659a1d4adcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2459619174","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅上涨9.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459619174","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459619174?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:32","pubTimestamp":1723642357,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时32分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速拉升9.62%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213237959885b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213237959885b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2459904429","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅上涨5.71%报0.465美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459904429","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459904429?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:53","pubTimestamp":1723557212,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时53分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速上涨5.71%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321533297198a82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321533297198a82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2458785517","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘快速拉升5.59%报0.457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458785517","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458785517?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:15","pubTimestamp":1723227318,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日02时15分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.32%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810021518941ffc83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810021518941ffc83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CVKD","BK4007"],"gpt_icon":0},{"id":"2458432680","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘股价大涨5.51%报0.437美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458432680","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458432680?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:46","pubTimestamp":1723142808,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时46分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速拉升5.51%。截至发稿，该股报0.437美元/股，成交量3.7186万股，换手率0.23%，振幅8.56%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.66%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809024648941ff840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809024648941ff840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CVKD","BK4139"],"gpt_icon":0},{"id":"2457184435","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.64%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457184435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457184435?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:33","pubTimestamp":1723037621,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时33分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅跳水5.64%。截至发稿，该股报0.400美元/股，成交量2.8773万股，换手率0.18%，振幅0.05%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133419585f212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133419585f212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2455695100","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅上涨5.76%报0.476美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455695100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455695100?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:06","pubTimestamp":1722351984,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日23时06分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升5.76%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302306249efe0e9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302306249efe0e9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2455667599","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455667599","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455667599?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:15","pubTimestamp":1722266126,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时15分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速跳水5.55%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231526968213c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231526968213c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CVKD","BK4139"],"gpt_icon":0},{"id":"2454328964","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.95%报0.458美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328964","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328964?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:49","pubTimestamp":1722001759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时49分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升5.95%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214920941fb201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214920941fb201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2454874946","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.27%报0.431美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454874946","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454874946?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:58","pubTimestamp":1721915928,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时58分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速下挫5.27%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725215848941faa02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725215848941faa02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2453037218","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453037218","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453037218?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:44","pubTimestamp":1721742240,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时44分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速拉升5.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232144009ee2bba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232144009ee2bba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":-0.1724},{"period":"1month","weight":0.4797},{"period":"3month","weight":0.7283},{"period":"6month","weight":0.4311},{"period":"1year","weight":0.2214},{"period":"ytd","weight":0.0812}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.04},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.1052},{"period":"1year","weight":0.3498},{"period":"ytd","weight":0.2055}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。他们专注于开发Tecarfarin，这是一种具有孤儿药适应症的新型疗法，旨在预防终末期肾病患者的心源性全身性血栓栓塞（血凝块）和心房颤动（心律不齐）或 AFib。Tecarfarin 是一种抗凝剂，其药物设计过程针对与血栓形成和 AFib 治疗中最常用的处方药不同的途径。他们于2022年4月1日通过 Horizon Technology Finance Corporation的全资子公司HESP LLC的资产购买协议获得了tecarfarin的权利。","exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}